+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 1
Age: 18Years - 55Years
All Genders
Healthy Volunteers
ID07783503

Evaluating How Phenytoin and Itraconazole Affect Pelabresib Levels in Healthy Adults A Two-Part Drug Interaction Study

Led by Novartis Pharmaceuticals · Updated on 2026-09-22

30

Participants Needed

1

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating how two drugs, phenytoin and itraconazole, affect the way pelabresib moves through the body in healthy adults aged 18 to 55. This Phase 1, open-label study aims to understand the interaction between these medications and to assess the safety and tolerability of pelabresib when taken alone or together with these drugs. The study has two parts, each with two treatment periods. In the first part, participants receive a single oral dose of pelabresib alone, followed by a single dose of pelabresib combined with repeated doses of phenytoin. In the second part, participants receive pelabresib alone, then pelabresib combined with repeated doses of itraconazole. These sequential treatments allow researchers to compare the effects of the drugs on pelabresib. Participants will undergo various assessments including blood sampling to measure pelabresib levels up to 72 hours after dosing, monitoring for side effects for about 30 days after the last dose, and health evaluations such as physical exams, vital signs, ECGs, and laboratory tests. The study focuses on measuring pelabresibs maximum concentration, exposure over time, and clearance from the body to understand its pharmacokinetics with and without the other drugs.

CONDITIONS

Brief Title

A Drug-drug Interaction Study to Assess the Effect of Phenytoin and Itraconazole on the Pharmacokinetics of Pelabresib in Healthy Participants

Research Team

N

Novartis Pharmaceuticals

N

Novartis Pharmaceuticals

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here